Neuroprotective effect of naloxone in inflammation-mediated dopaminergic neurodegeneration. Dissociation from the involvement of opioid receptors.
Liu
Bin
B
Neuropharmacology Section, National Institute of Environmental Health Science, National Institutes of Health, Research Triangle Park, NC, USA.
Hong
Jau-Shyong
JS
D000818:Animals; D004298:Dopamine / Q000378:metabolism*; D006801:Humans; D007249:Inflammation / Q000378:metabolism; D009270:Naloxone / Q000494:pharmacology*; D009292:Narcotic Antagonists / Q000494:pharmacology*; D009410:Nerve Degeneration; D019636:Neurodegenerative Diseases / Q000378:metabolism / Q000517:prevention & control*; D018696:Neuroprotective Agents / Q000494:pharmacology*
D009292:Narcotic Antagonists; D018696:Neuroprotective Agents; D009270:Naloxone; D004298:Dopamine